The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma.
 
Geoffrey Yuyat Ku
Consulting or Advisory Role - Lilly; Merck Sharp & Dohme; Pieris Pharmaceuticals
Research Funding - Arog (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); MedImmune (Inst); Merck (Inst); Oncolys BioPharma (Inst); Pieris Pharmaceuticals (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Aduro Biotech; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Sharp & Dohme; Pieris Pharmaceuticals
 
Abraham Jing-Ching Wu
Stock and Other Ownership Interests - Simphotek
Consulting or Advisory Role - AstraZeneca; MORE Health
Research Funding - CivaTech Oncology
Travel, Accommodations, Expenses - Alpha Tau; CivaTech Oncology
 
Smita Sihag
No Relationships to Disclose
 
Bernard J. Park
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Intuitive Surgical
 
David Randolph Jones
Consulting or Advisory Role - AstraZeneca; Diffusion Pharmaceuticals; Merck
 
Ping Gu
No Relationships to Disclose
 
Steven Brad Maron
Stock and Other Ownership Interests - Calithera Biosciences
Honoraria - Clinical Care Options; MedEd; RMEI Medical Education
Consulting or Advisory Role - Health Advances
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck
 
Ryan Sugarman
No Relationships to Disclose
 
Sree Bhavani Chalasani
No Relationships to Disclose
 
Marina Shcherba
No Relationships to Disclose
 
Lara Feder
No Relationships to Disclose
 
Kendall Cowie
No Relationships to Disclose
 
Jaclyn Norris
Stock and Other Ownership Interests - Bridge Connector (I)
Consulting or Advisory Role - Deloitte (I)
 
Valerie Johnson
No Relationships to Disclose
 
Laura H. Tang
No Relationships to Disclose
 
David H. Ilson
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly/ImClone; Merck; Pieris Pharmaceuticals; Roche/Genentech; Taiho Pharmaceutical
 
Yelena Y. Janjigian
Stock and Other Ownership Interests - Rgenix
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Imugene; Jounce Therapeutics; Lilly; Merck; Merck Serono; Merck Sharpe and Dohme Corp.; Michael J. Hennessy Associates; Ono Pharmaceutical; Paradigm; Peerview; Pfizer; Physicans' Education Resource; Rgenix; Seagen; Zymeworks
Research Funding - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Lilly; Merck; Rgenix (Inst); Roche
 
Daniela Molena
No Relationships to Disclose